VeriSign R&D increased by 3.8% to $27.50M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 5.8%, from $26.00M to $27.50M. Over 4 years (FY 2021 to FY 2025), R&D shows an upward trend with a 6.5% CAGR.
Analysis
StatementIncome Statement
SectionOperating Expenses
CategoryGrowth
SignalContext dependent
VolatilityModerate
First reportedQ1 2014
Last reportedQ1 2026
How to read this metric
Higher spending signals a commitment to innovation and future product launches, whereas significant cuts may indicate a shift toward short-term profitability.
Detailed definition
Research and development expenses represent the costs incurred to discover new products, improve existing technologies,...
Peer comparison
Highly comparable across pharmaceutical and medical device peers, where R&D intensity is a key metric for long-term valuation.
Metric ID:
research_and_developmentHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $19.80M | $19.60M | $20.80M | $22.90M | $20.30M | $21.00M | $21.50M | $24.20M | $22.20M | $21.70M | $22.90M | $24.80M | $23.80M | $23.20M | $24.90M | $26.00M | $25.70M | $25.40M | $26.50M | $27.50M |
| QoQ Change | — | -1.0% | +6.1% | +10.1% | -11.4% | +3.4% | +2.4% | +12.6% | -8.3% | -2.3% | +5.5% | +8.3% | -4.0% | -2.5% | +7.3% | +4.4% | -1.2% | -1.2% | +4.3% | +3.8% |
| YoY Change | — | — | — | — | +2.5% | +7.1% | +3.4% | +5.7% | +9.4% | +3.3% | +6.5% | +2.5% | +7.2% | +6.9% | +8.7% | +4.8% | +8.0% | +9.5% | +6.4% | +5.8% |
Range$19.60M – $27.50M
CAGR+7.2%
Avg YoY Growth+6.1%
Median YoY Growth+6.5%
Current Streak2 quarters growth
R&D at Other Companies
Frequently Asked Questions
- What is VeriSign's r&d?
- VeriSign (VRSN) reported r&d of $27.50M in Q1 2026.
- How has VeriSign's r&d changed year-over-year?
- VeriSign's r&d increased by 5.8% year-over-year, from $26.00M to $27.50M.
- What is the long-term trend for VeriSign's r&d?
- Over 4 years (2021 to 2025), VeriSign's r&d has grown at a 6.5% compound annual growth rate (CAGR), from $80.50M to $103.60M.
- What does r&d mean?
- The money spent on creating new products or improving existing ones to drive future growth.